TY - JOUR AU - Chang, Hsin-Wen AU - Yan, Di AU - Singh, Rasnik AU - Liu, Jared AU - Lu, Xueyan AU - Ucmak, Derya AU - Lee, Kristina AU - Afifi, Ladan AU - Fadrosh, Douglas AU - Leech, John AU - Vasquez, Kimberly S. AU - Lowe, Margaret M. AU - Rosenblum, Michael D. AU - Scharschmidt, Tiffany C. AU - Lynch, Susan V. AU - Liao, Wilson PY - 2018 DA - 2018/09/05 TI - Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization JO - Microbiome SP - 154 VL - 6 IS - 1 AB - Psoriasis impacts 1–3% of the world’s population and is characterized by hyper-proliferation of keratinocytes and increased inflammation. At the molecular level, psoriasis is commonly driven by a Th17 response, which serves as a major therapeutic target. Microbiome perturbations have been associated with several immune-mediated diseases such as atopic dermatitis, asthma, and multiple sclerosis. Although a few studies have investigated the association between the skin microbiome and psoriasis, conflicting results have been reported plausibly due to the lack of standardized sampling and profiling protocols, or to inherent microbial variability across human subjects and underpowered studies. To better understand the link between the cutaneous microbiota and psoriasis, we conducted an analysis of skin bacterial communities of 28 psoriasis patients and 26 healthy subjects, sampled at six body sites using a standardized protocol and higher sequencing depth compared to previous studies. Mouse studies were employed to examine dermal microbial-immune interactions of bacterial species identified from our study. SN - 2049-2618 UR - https://doi.org/10.1186/s40168-018-0533-1 DO - 10.1186/s40168-018-0533-1 ID - Chang2018 ER -